eISSN: 2449-8580
ISSN: 1734-3402
Family Medicine & Primary Care Review
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search

Open access

without publication fees
4/2020
vol. 22
 
Share:
Send email
Share:
Original paper

Role of the atherogenic index of plasma in the prediction of the urinary albumin excretion and macrovascular complications in patients with type 2 diabetes

Usama Ragab
1
,
Fayrouz Othman Selim
1
,
Ahmed Ibrahim El Agroody
1
,
Mohamed Hossam Eldin Mourad
2
,
Mohamed Mohamed Sakr
1

  1. Internal Medicine Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt
  2. Clinical Pathology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt
Family Medicine & Primary Care Review 2020; 22(4): 312–318
DOI: https://doi.org/10.5114/fmpcr.2020.100437
Online publish date: 2020/12/29
Article file
- 09 FM&PCR 4 20 - O - Ragab - Role - 708.pdf  [0.51 MB]
Get citation
 
PlumX metrics:
 
1. International Diabetes Federation. IDF Diabetes Atlas. 8th ed. Brussels: International Diabetes Federation, 2017. Available from URL: http://www.diabetesatlas.org.
2. American Diabetes Association. 10. Cardiovascular disease and risk management: standards of medical care in diabetes – 2019. Diabetes Care 2019; 42(Suppl. 1): S103–S123.
3. Akbas EM, Timuroglu A, Ozcicek A, et al. Association of uric acid, atherogenic index of plasma and albuminuria in diabetes mellitus. Int J Clin Exp Med 2014; 7(12): 5737–5743.
4. Millán J, Pintó X, Muñoz A, et al. Lipoprotein ratios: physiological significance and clinical usefulness in cardiovascular prevention. Vasc Health Risk Manag 2009; 5: 757–765.
5. Dobiášová M, Frohlich J, Šedová M, et al. Cholesterol esterification and atherogenic index of plasma correlate with lipoprotein size and findings on coronary angiography. J Lipid Res 2011; 52(3): 566–571.
6. Wang Y, Yuan A, Yu C. Correlation between microalbuminuria and cardiovascular events. Int J Clin Exp Med 2013; 6(10): 973–978.
7. American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes – 2019. Diabetes Care 2019; 42(Suppl. 1): S13–S28.
8. Levin A, Stevens PE, Bilous RW, et al. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013; 3(1): 1–50.
9. Bhardwaj S, Bhattacharjee J, Bhatnagar MK, et al. Atherogenic index of plasma, castelli risk index and atherogenic coefficient-new parameters in assessing cardiovascular risk. Int J Pharm Biol Sci 2013; 3(3): 359–364.
10. Khazaál MS. Atherogenic index of plasma (AIP) as a parameter in predicting cardiovascular risk in males compared to the conventional dyslipidemic indices (cholesterol ratios). Kerbala Jorunal of Medicine 2013; 6(1): 1506–1513.
11. Adu EM, Ukwamedu HA, Oghagbon ES. Assessment of cardiovascular risk indices in type 2 diabetes mellitus. Trop Med Surg 2015; 3(184): 1–4.
12. Nimmanapalli HD, Kasi AD, Devapatla PK, et al. Lipid ratios, atherogenic coefficient and atherogenic index of plasma as parameters in assessing cardiovascular risk in type 2 diabetes mellitus. Int J Res Med Sci 2016; 4(7): 2863–2869.
13. Dobiás̆ová M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apob-lipoprotein-depleted plasma (FERHDL). Clin Biochem 2001; 34(7): 583–588.
14. Ridker PM, Danielson E, Fonseca FA, et al. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet 2009; 373(9670): 1175–1182.
15. Regmi P, Baral B, Raut M, et al. Atherogenic index of plasma for prediction of future cardiovascular disease in prediabetes and diabetes population. Atherosclerosis 2016; 252: e120, doi: 10.1016/j.atherosclerosis.2016.07.636.
16. Anjum M, Uddin MS, Tamanna NA, et al. Evaluation of lipid profile pattern and atherogenic index of plasma (AIP) having type-2 diabetes mellitus in Bangladesh. Int J Res Med Sci 2018 6(3): 776–783.
17. Bo MS, Cheah WL, Lwin S, et al. Understanding the relationship between atherogenic index of plasma and cardiovascular disease risk factors among staff of an University in Malaysia. J Nutr Metab 2018; 2018: 7027624, doi: 10.1155/2018/7027624.
18. Suchitra MM, Sheshu KM, Bitla AR, et al. Atherogenic dyslipidemia in diabetic nephropathy: lipoprotein (a), lipid ratios and atherogenic index. Int J Res Med Sci 2013; 1(4): 455–459.
19. Jia L, Wei Z, Yajing Z, et al. Relationship between atherogenic index of plasma and diabetic nephropathy in patients with type 2 diabetes mellitus. Chin J Clin 2014; 14: 2570–2573.
20. Hung CC, Tsai JC, Kuo HT, et al. Dyslipoproteinemia and impairment of renal function in diabetic kidney disease: an analysis of animal studies, observational studies, and clinical trials. Rev Diabet Stud 2013; 10: 110–120.
21. Leon BM, Maddox TM. Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabetes 2015; 6(13): 1246–1258.
22. Gerstein HC, Mann JF, Yi Q, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001; 286(4): 421–426.
Copyright: © 2020 Family Medicine & Primary Care Review. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
  
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.